For the year ending 2025-12-31, HIT had -$179,494 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 1,278,842 |
| Bad debt expense (recovery) | -16,234 |
| Amortization expense | 900,577 |
| Provision for refund liability | 3,891,598 |
| Provision for credit losses on other receivables | 377,587 |
| Deferred tax expenses (benefits) | 428,999 |
| Interest income | 64,000 |
| Stock-based compensation expense | 1,570,419 |
| Accounts receivable | -907,049 |
| Other receivables | 3,345,149 |
| Prepaid expenses and other assets | 1,948,184 |
| Operating lease right-of-use assets and liabilities, net | 551 |
| Accounts payable and accrued expenses | 2,358,113 |
| Income taxes payable | -205,253 |
| Other current liabilities | -3,000,000 |
| Net cash provided by operating activities | 3,133,813 |
| Development of software | 3,189,921 |
| Interest received from loans receivable | 64,000 |
| Net cash used in investing activities | -3,125,921 |
| Proceeds from stock option exercises | 23,430 |
| Payments of deferred offering costs | 210,816 |
| Net cash provided by (used in) financing activities | -187,386 |
| Increase (decrease) in cash and cash equivalents | -179,494 |
| Cash and cash equivalents, beginning of year | 7,849,248 |
| Cash and cash equivalents, end of year | 7,669,754 |
Health In Tech, Inc. (HIT)
Health In Tech, Inc. (HIT)